Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Dec 08, 2020 6:54pm

58 Views

Post# 32063794

todays trades

House Positions for C:VXL from 20201208 to 20201208

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
79 CIBC	124,000	10,540	0.085	11,000	935	0.085	113,000	-9,605
9 BMO Nesbitt	106,000	9,540	0.09	22,000	1,930	0.088	84,000	-7,610
89 Raymond James	5,500	495	0.09	0			5,500	-495
124 Questrade	2,000	170	0.085	2,000	170	0.085	0	0
80 National Bank	10,000	900	0.09	10,000	900	0.09	0	0
85 Scotia	2,000	170	0.085	2,000	170	0.085	0	0
68 Leede	563	47	0.083	989	89	0.09	-426	42
88 Credential	0			10,600	901	0.085	-10,600	901
2 RBC	67,800	5,953	0.088	102,000	9,035	0.089	-34,200	3,082
1 Anonymous	38,000	3,230	0.085	114,200	10,142	0.089	-76,200	6,912
7 TD Sec	168,989	14,669	0.087	250,063	21,442	0.086	-81,074	6,773
TOTAL	524,852	45,714	0.087	524,852	45,714	0.087	0	0